News from sirtex medical limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

03 Jul, 2017, 08:30 BST New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer

SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line...


05 Jun, 2017, 14:27 BST SIR-Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds

Final Results of SIRveNIB Study presented at 2017 American Society of Clinical Oncology Meeting For the second time in less than two months, a major...


24 May, 2017, 08:09 BST Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows

Surgeons' blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated...


24 Apr, 2017, 07:00 BST SIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows

459-patient SARAH Study shows that local treatments of advanced or inoperable Hepatocellular Cancer (HCC) with SIR-Spheres Y-90 resin microspheres...


11 Oct, 2016, 09:00 BST New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)

Sirtex Medical Limited (ASX: SRX) announced today that the European Society of Medical Oncology (ESMO) has indicated the use of SIRT using yttrium-90 ...


01 Jul, 2016, 08:30 BST Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows

New data presented by Prof. Dr. Volker Heinemann in an oral abstract session at the European Society of Medical Oncology's 18th World Congress on...


23 Feb, 2016, 08:00 GMT SIRFLOX Study Published in Journal of Clinical Oncology

Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the Management of Metastatic Colorectal...


19 Jan, 2016, 20:28 GMT Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows

606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 years) Patients with Liver-Dominant...


04 Jul, 2015, 10:30 BST New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer

Adding SIR-Spheres® Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver...


30 May, 2015, 22:00 BST SIRFLOX Study Presented at ASCO 2015 Annual Meeting

Clinical investigators cite significance of 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable metastatic ...


17 Mar, 2015, 08:00 GMT Sirtex Reports Preliminary SIRFLOX Study Results

In the first-line treatment of non-resectable metastatic colorectal cancer: SIRFLOX study does not show a statistically significant improvement in...


29 Jan, 2015, 15:54 GMT FOXFIRE and FOXFIRE Global Studies Complete Patient Enrolment

Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line SIR-Spheres® Y-90 resin...


24 Jul, 2013, 17:36 BST Innovative Cancer Treatment Supported by NICE

NEW UK GUIDANCE SHOULD IMPROVE PATIENT ACCESS TO SIR-SPHERES® MICROSPHERES FOR PRIMARY LIVER CANCER The UK National Institute for Health and Clinical ...


13 Dec, 2012, 11:40 GMT Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours

http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied form of SIRT for all cancers in...


11 Dec, 2012, 08:00 GMT Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours

http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied form of SIRT for all cancers in...


11 Dec, 2012, 08:00 GMT Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours

http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied form of SIRT for all cancers in...


03 Feb, 2012, 08:11 GMT Un nuevo estudio del cáncer de hígado primario busca reclutar a 400 pacientes franceses

'SARAH', un ensayo controlado aleatorio colaborativo nacional francés de radioembolización con microesferas de resina yttrium-90 frente a sorafenib...


03 Feb, 2012, 07:00 GMT Une nouvelle étude sur le cancer primitif du foie cherche à recruter 400 patients français

SARAH, une étude nationale française collaborative randomisée contrôlée sur la radioembolisation utilisant des microsphères d'yttrium-90 en résine...


03 Feb, 2012, 07:00 GMT New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients

'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in...